Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y2NN
|
|||
| Former ID |
DNCL003227
|
|||
| Drug Name |
Replication-defective HIV-1 vaccine
|
|||
| Synonyms |
HIVAX (TN)
Click to Show/Hide
|
|||
| Indication | Human immunodeficiency virus-1 infection [ICD-11: 1C62; ICD-10: B20-B24] | Phase 1 | [1] | |
| Company |
GeneCure Biotechnologies
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01428596) Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.